These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 156221)

  • 1. Lung tumor-reactive cytotoxic lymphocytes generated in mixed lymphocyte reaction between C3HfeB/HeN (H-2kb) and C3H/HeN (H-2k) strain mice.
    Imamura M; Gipson TG; Bensky N; Justice R; Martin WJ
    J Immunol; 1979 May; 122(5):1863-6. PubMed ID: 156221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histocompatibility difference between C3HfeB/HeN and C3H/HeN mice: tumour induced in C3HfeB/HeN mice expresses C3H/HeN-associated alloantigen.
    Martin WJ; Gipson TG; Conliffe MA; Cotton WG; Dove LF; Rice JM
    J Immunogenet; 1978 Aug; 5(4):255-60. PubMed ID: 83342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-2K/H-2D and Mls and I region-associated antigens stimulate helper factor(s) involved in the generation of cytotoxic T lymphocytes.
    Scott JW; Ponzio NM; Orosz CG; Finke JH
    J Immunol; 1980 May; 124(5):2378-83. PubMed ID: 6444971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
    Callahan GN
    J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
    Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
    J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1978 Sep; 121(3):1045-51. PubMed ID: 151115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helper cells in the autologous mixed lymphocyte reaction. I. Generation of cytotoxic T cells recognizing modified self H-2.
    Wolos JA; Smith JB
    J Immunol; 1981 Aug; 127(2):711-5. PubMed ID: 6454726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limiting dilution analysis of alloantigen-reactive T lymphocytes. V. Lyt phenotype of cytolytic T lymphocyte precursors reactive against normal and mutant H-2 antigens.
    Cerottini JC; MacDonald HR
    J Immunol; 1981 Feb; 126(2):490-6. PubMed ID: 6450245
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuously proliferating T killer cells specific for H-2b targets: selection and characterization.
    Dennert G; De Rose M
    J Immunol; 1976 Jun; 116(6):1601-6. PubMed ID: 58039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cytotoxic lymphocyte responses in vitro by alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1977 Jul; 119(1):31-7. PubMed ID: 874322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of alloantigen-induced cytotoxic responses by concanavalin A-activated lymphoid cells: suppression by antigen elimination.
    Kastner DL; Rich RR
    J Immunol; 1978 Nov; 121(5):1732-7. PubMed ID: 712063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.
    Wettstein PJ; Colombo MP
    J Immunol; 1987 Oct; 139(7):2166-71. PubMed ID: 2958540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption of normal lymphocytes on allogeneic spleen monolayers: depletion of alloreactivity is due to inhibition of CTL induction by released monolayer cells.
    Kelso A
    J Immunol; 1981 Oct; 127(4):1563-9. PubMed ID: 6456308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary in vitro cytotoxic response of F1 T lymphocytes against parental antigens.
    Ishikawa H; Dutton RW
    J Immunol; 1979 Feb; 122(2):529-36. PubMed ID: 310842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.